Stephan Jackman
Chief Executive Officer at ALZAMEND NEURO, INC.
Net worth: 3 033 $ as of 2024-03-30
Stephan Jackman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALZAMEND NEURO, INC. | Director/Board Member | 2020-08-31 | - |
| Chief Executive Officer | 2018-11-19 | - |
Career history of Stephan Jackman
Former positions of Stephan Jackman
| Companies | Position | Start | End |
|---|---|---|---|
| Exit 9 Technologies, Inc. | Chief Operating Officer | 2017-09-30 | 2018-10-31 |
Ennaid Therapeutics LLC
 Ennaid Therapeutics LLC BiotechnologyHealth Technology Ennaid Therapeutics LLC develops orally deliverable anti-viral peptide that treats and prevents Zika virus. The company was founded by Darnisha Grant Harrison in 2012 and is headquartered in Alpharetta, GA. | Chief Operating Officer | 2015-09-30 | 2017-09-30 |
Training of Stephan Jackman
| Stevens Institute of Technology | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Operating Officer | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALZAMEND NEURO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Ennaid Therapeutics LLC
Ennaid Therapeutics LLC BiotechnologyHealth Technology Ennaid Therapeutics LLC develops orally deliverable anti-viral peptide that treats and prevents Zika virus. The company was founded by Darnisha Grant Harrison in 2012 and is headquartered in Alpharetta, GA. | Health Technology |
| Exit 9 Technologies, Inc. |
- Stock Market
- Insiders
- Stephan Jackman
- Experience
